Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Labeler | NDC Package Code | Non Proprietary Name | Start Marketing Date | End Marketing Date | Category Code | Dosage Form (Strength) |
|---|---|---|---|---|---|---|---|---|---|
| 28/03/2025 | Boehringer Ingelheim GmbH |
Germany |
Boehringer Ingelheim Pharma GmbH and Co. KG | 12714-219 | Tafasitamab | 2020-07-31 | 2025-12-31 | DRUG FOR FURTHER PROCESSING | POWDER (200mg/200mg) |
